All Type of News


Domestic firms’ strategic alliances with multinational firms up

A number of domestic pharmaceutical companies have already established strategic alliances with multinational drug manufacturers for co-marketing and/or co-development of new drugs to effectively minimize outlays for ...

Court dismisses Dong-A’s collusion over Valtrex

The Seoul Higher Court ruled Wednesday that Dong-A Pharm did not collude with GlaxoSmithKline (GSK) over the sales of GSK’s Valtrex (valaciclovir). Therefore, the court said that the fines imposed by the Fair Trade...

Chairman Kim become largest shareholder at Handok

Handok Pharm Wednesday said in its regulatory filing that incumbent chairman Kim Young-jin is the largest shareholder as the company acquired a 50 percent stake from Hoechst. The acquisition aims at protecting the ...

Government urged to come up with shortage of pharmacists

It is estimated there will be a deficit of 2,400 pharmacists in 2013-14, as a result of a transition period in school years from the current four to six from this year, according to pharmaceutical industry sources. ...

BMS Korea’s labor dispute is still going on

BMS and unionists are still on a collision course as no headway has been reached on a wage deal with management since June "Workers are always angry at the decision by the company to raise their annual wages while ...

Korea emerging as global drug trial hub

Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research. The appeal is the country’s highly qualified med...

SK Chemicals’ largest GMP plant completed

SK Chemicals Co. has completed its largest GMP plant in Chungju, North Chungcheong Province as part of its efforts to expand the annual production of solid forms and patch. A completion ceremony was held Tuesday, 1...

Multiple myeloma patients calls for earlier insurance coverage of Revlimid

A group of patients suffering from multiple myeloma claimed that the national health insurance should cover Revlimid (lenalidomide) at an earlier date. In a meeting with the National Health Insurance Corporation (N...

New prescription plan is burdensome to drug makers

In a 2013 medical service fee negotiation with the National Health Insurance Corporation, the Korean Medical Association opposed new prescription plan, under which doctors will be required to prescribe the actual chem...

Heads of rural village may sell OTC drugs

The Ministry of Health and Welfare issued the newly revised regulation last Friday, in which heads of villages will be allowed to sell cold remedies, digestive tablets, and painkillers if there are no alternative plac...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.